idarubicin has been researched along with Cardiotoxicity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Chang, X; Li, L; Li, Y; Lin, R; Liu, N; Liu, X; Peng, X; Ruan, Y; Tang, R; Wang, X; Wen, S | 1 |
| Amin Hashemipour, SM; Hosseinpour, H; Keshavarzian, E; Khamas, SS; Kogani, M; Moazen, M; Mortazavizadeh, SM; Motevalipoor, AF; Sadighpour, T; Soltani, M; Valizadeh, R | 1 |
| Arao, Y; Fujimoto, K; Fukaya, K; Furusawa, K; Haga, T; Hiraiwa, H; Kano, N; Kato, H; Kondo, T; Kuwayama, T; Morimoto, R; Murohara, T; Mutsuga, M; Oishi, H; Okumura, T; Sawamura, A; Shimizu, S; Sugiura, Y; Usui, A; Watanabe, N; Yamaguchi, S; Yokoi, T | 1 |
| Fernández-Medarde, A; Fuentes-Mateos, R; García-Navas, R; Juan, AO; Sánchez-López, JM; Santos, E | 1 |
| Hu, M; Jiang, H; Xia, M | 1 |
2 review(s) available for idarubicin and Cardiotoxicity
| Article | Year |
|---|---|
The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Calcium; Cardiotoxicity; Daunorubicin; Doxorubicin; Epirubicin; Humans; Idarubicin; Mitochondria; Mitochondrial Proteins; Myocytes, Cardiac; Reactive Oxygen Species | 2022 |
Prophylactic Agents for Preventing Cardiotoxicity Induced Following Anticancer Agents: A Systematic Review and Meta-Analysis of Clinical Trials.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotoxicity; Dexrazoxane; Humans; Idarubicin; Neoplasms | 2023 |
3 other study(ies) available for idarubicin and Cardiotoxicity
| Article | Year |
|---|---|
Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotoxicity; Daunorubicin; Device Removal; Disease Progression; Female; Fibrosis; Heart-Assist Devices; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Myocardium; Time Factors; Ventricular Function, Left | 2020 |
Anthraquinones as Inhibitors of SOS RAS-GEF Activity.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Cardiotoxicity; Cell Line, Transformed; Cell Line, Tumor; Doxorubicin; Epithelial Cells; Fibroblasts; GTP Phosphohydrolases; Humans; Idarubicin; Membrane Proteins; Mice; Mice, Knockout; Proto-Oncogene Proteins p21(ras); Small Molecule Libraries; Son of Sevenless Proteins; SOS1 Protein | 2021 |
[NT-pro-BNP in the evaluation of daunorubicin-indued cardiotoxicity in acute childhood leukemia].
Topics: Anthracyclines; Cardiotoxicity; Daunorubicin; Humans; Idarubicin; Leukemia | 2010 |